ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651774 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651774; 2) Community: the network communities that were significantly associated with the response to NSC 651774; 3) Molecule: the relationships between components within communities and NSC 651774; 4) MDR: the compounds that were significantly associated with the NSC 651774.

NSC Compound Enrichment Correlation
NSC 606498 Camptothecin Derivative 0.0312262198176283 0.50419486
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0312262198176283 0.33364782
NSC 639174 Camptothecin Derivative 0.0312262198176283 0.34948046
NSC 639186 Raltitrexed 0.0312262198176283 0.43667761
NSC 642954 Null 0.0312262198176283 0.47413223
NSC 100880 Camptothecin 0.0352383000003056 0.37345053
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0352383000003056 0.24584684
NSC 164991 Null 0.0352383000003056 -0.059353843
NSC 254665 JUSTICIDIN B 0.0352383000003056 0.32917793
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0352383000003056 0.57435938
Total:43  Current:26    [First] [Prev] [Next] [Last]